Standard BioTools financial statements

스탠더드 바이오툴스NASDAQ:LAB · Nasdaq · Healthcare
$0.7447+2.25%
2026-10-02 close

Standard BioTools's published financial data is dated 2026-10-04. 2024 revenue was $174M. 2024 operating profit was −$150M.

Reported results

Standard BioTools notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q